Treatment of Pulmonary Sarcoidosis Using Allogenic Bone Marrow-Derived Mesenchymal Stem Cell Therapy is Safe: A Case Report | Zendy

AI Assistant Blog Pricing

Open Access

Treatment of Pulmonary Sarcoidosis Using Allogenic Bone Marrow-Derived Mesenchymal Stem Cell Therapy is Safe: A Case Report

Author(s) -

Eduard Pavelić

Publication year - 2022

Publication title -

international journal of medical science and clinical research studies

Language(s) - English

Resource type - Journals

eISSN - 2767-8342

pISSN - 2767-8326

DOI - 10.47191/ijmscrs/v2-i6-12

Subject(s) - medicine , mesenchymal stem cell , bone marrow , surgery , pathology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.